← Leaderboards
Edwin C Agbo
Fyodor Biotechnologies, Inc
$916,438
Attributed
$916,438
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $736.4K · FY2011–12$1M$750K$500K$250K$0
'11
'12
Funding mix
By agency
NSF$916,438 · 3
By mechanism
—$916,438 · 3
Top collaborators
No co-investigators on record.
Grant awards (3)
SBIR Phase II: Broad-based Urine Test for the Diagnosis of Plasmodium falciparum and P. vivax Malaria In Febrile Patients$571,438
· FY2012 · TIP · contact PI
SBIR Phase I: Recombinant Multiepitope Mosaic Protein Design for Urine-based Diagnosis of Leptospirosis$165,000
· FY2012 · TIP · contact PI
SBIR Phase I: Novel Urine-excreted Plasmodium Falciparum and P. vivax Poly-asparagine Proteins as Targets for Bi-specific Monoclonal Antibody and Urine Malaria Test Development$180,000
· FY2011 · TIP · contact PI